Lexeo Therapeutics, Inc. (LXEO) Payables (2022 - 2023)
Lexeo Therapeutics' Payables history spans 2 years, with the latest figure at $6.8 million for Q3 2023.
- For Q3 2023, Payables changed N/A year-over-year to $6.8 million; the TTM value through Sep 2023 reached $6.8 million, changed N/A, while the annual FY2022 figure was $2.7 million, N/A changed from the prior year.
- Payables for Q3 2023 was $6.8 million at Lexeo Therapeutics, up from $2.7 million in the prior quarter.
- Across five years, Payables topped out at $6.8 million in Q3 2023 and bottomed at $2.7 million in Q4 2022.